L. Langkjaer

Soluble, prolonged-acting insulin derivatives. III. Degree of protraction, crystallizability and chemical stability of insulins substituted in positions A21, B13, B23, B27 and B30.

P. Hougaard, K. Norris, J. Markussen, 1988, Protein engineering.

Application of the euglycaemic clamp technique to bioassay of insulin analogues.

D. Owens, U. Ribel, A. Vølund, 1992, Biologicals : journal of the International Association of Biological Standardization.

NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.

A. Vaag, P. Hougaard, J. Markussen, 1989, BMJ.

Soluble, prolonged-acting insulin derivatives. II. Degree of protraction and crystallizability of insulins substituted in positions A17, B8, B13, B27 and B30.

P. Hougaard, U. Ribel, K. Norris, 1987, Protein engineering.

Chemical stability of insulin. 3. Influence of excipients, formulation, and pH.

J. Brange, L. Langkjaer, 1992, Acta pharmaceutica Nordica.

Insulin formulation and delivery.

J. Brange, L. Langkjaer, 1997, Pharmaceutical biotechnology.

Iontophoresis of monomeric insulin analogues in vitro: effects of insulin charge and skin pretreatment.

R. Guy, G. Grodsky, J. Brange, 1998, Journal of controlled release : official journal of the Controlled Release Society.

Precipitation of insulin aspart and insulin glulisine products used for continuous subcutaneous insulin infusion.

L. Langkjaer, C. Poulsen, Carsten Worsøe, 2007, Diabetes technology & therapeutics.

Precipitation of insulin products used for continuous subcutaneous insulin infusion.

L. Langkjaer, C. Poulsen, Carsten Worsøe, 2005, Diabetes technology & therapeutics.

Insulin analogues with improved absorption characteristics.

U. Ribel, J. Markussen, J. Brange, 1992, Hormone and metabolic research. Supplement series.